Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELVET: Veltuzumab in Rheumatoid Arthritis
NCT01390545Phase 2Terminated
- Sponsor
- Takeda
- Start
- Aug 2011
- Primary completion
- Oct 2012
- Modality
- IgG Antibodies
- Countries
- 11
01
Overview
A Phase 2 trial of veltuzumab in rheumatoid arthritis (RA), sponsored by Takeda. Started Aug 2011; status: terminated.
02
Drugs
veltuzumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01390545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01390545.